Adverse effects of ketoprofen after intrauterine exposure. Prognostic value of its measurement in plasma?;LES EFFETS SECONDAIRES DU KETOPROFENE APRES EXPOSITION INTRA-UTERINE. INTERET DU DOSAGE PLASMATIQUE

Archives de Pediatrie

Volumn 3, Issue 3, 1996, Pages 248-253

  Llanas, B ^a   Cavert, M H ^a   Apere, H ^a   Demarquez, J L ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

anti inflammatory agents, non steroidal; drug tolerance; fetus; infant; newborn; phenylpropionates; pregnancy

Indexed keywords

KETOPROFEN; PROSTAGLANDIN SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FATALITY; FEMALE; FETUS; HUMAN; KIDNEY FAILURE; MALE; NEWBORN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; BLOOD; CASE REPORT; DRUG TOLERANCE; FETOMATERNAL TRANSFUSION; PREGNANCY; PRENATAL EXPOSURE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG TOLERANCE; FEMALE; HUMANS; INFANT, NEWBORN; KETOPROFEN; MALE; MATERNAL-FETAL EXCHANGE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TOCOLYTIC AGENTS;

EID: 0029880773     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-693X(96)81303-0     Document Type: Article

References (12)

1. Bavoux F, Bodiou C, Carlus C. Toxicité fœtale des anti-inflammatoires non stéroïdiens. Arch Fr Pédiatr 1992;49:453-66
2. Mignot G, Bavoux F. En fin de grossesse, les anti-inflammatoires sont dangereux pour le fœtus. Prescrire 1991;109:363-6
3. Simeoni U, Messer J, Weisburd P, Haddad J, Willard D. Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 1989;148:371-3
4. Moss Dutartre T. Antì-inflammatoires non stéroïdiens et grossesse. Thèse de médecine. Nantes, 1989
5. Netter JC, Choulot JJ, Dagues-Bìe M, Rance F, Saint-Martin J, Petrus M. Oligoamnios et hypertension artérielle pulmonaire néonatale. Rôle du kétoprofène pendant la grossesse. Sem Hôp Paris 1990;66:1953-4
6. Guignard JP, Gouyon JB. Adverse effects of drugs on the immature kidney. Biol Neonate 1988;53:243-52
7. Bavoux F, Bodiou C, Olive G. Observations de néphrotoxicité en période périnatale. Bilan des centres de pharmacovigilance. Thérapie 1988;43:413-6
8. Marpeau L, Bouillie J, Barrat J, Milliez J. Obstetrical advantages and perinatal risks of indomethacin: a report of 818 cases. Fetal Diagn Ther 1994;9:110-5
9. Guignard JP. Le rein immature. Méd/Sci 1993;9:289-96
10. Gouyon JB, Petion AM, Sandre D, Sgro C, Bavoux F. Insuffisance rénale néonatale et exposition intra-utérìne au kétoprofène. Arch Fr Pédiatr 1991;48:347-8
11. Gouyon JB, Guignard JP. Insuffisance rénale vasomotrice du nouveau-né. Physiopathologie et traitement. Arch Fr Pédiatr 1989;46:137-41
12. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7